Showing results (261-270 of 328) with videos related to

Sort By:
Pageof 33
Circulation. Cardiovascular Quality and Outcomes|February 3, 2025
Quality of Life Outcomes With a Risk-Based Precision Testing Strategy Versus Usual Testing in Stable Patients With Suspected Coronary Disease: Results From the PRECISE Randomized TrialDaniel B Mark, Yanhong Li, Michael G Nanna, et al.
European Journal of Heart Failure|March 3, 2022
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fractionClara Saldarriaga, Dan Atar, Amanda Stebbins, et al.
Annals of Internal Medicine|September 16, 2014
Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trialDaniel B Mark, J David Knight, Eric J Velazquez, et al.
JACC. Heart Failure|September 8, 2014
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart FailureG Michael Felker, Tariq Ahmad, Kevin J Anstrom, et al.
JACC. Heart Failure|February 16, 2024
Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection FractionRobert J Mentz, Amanda Stebbins, Javed Butler, et al.
American Heart Journal|May 3, 2005
Conducting economic evaluations alongside multinational clinical trials: toward a research consensusShelby D Reed, Kevin J Anstrom, Ameet Bakhai, et al.
Journal of Cardiac Failure|August 30, 2025
Assessing Benefit in Heart Failure Patients with Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk StratificationChristopher M O'Connor, Sarah Rathwell, Devan V Mehrotra, et al.
JACC. Heart Failure|December 30, 2014
Primary prevention implantable cardioverter-defibrillators and survival in older womenEmily P Zeitler, Anne S Hellkamp, Gregg C Fonarow, et al.
JAMA|October 20, 2020
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical TrialPaul W Armstrong, Carolyn S P Lam, Kevin J Anstrom, et al.
JAMA Cardiology|April 23, 2020
Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical TrialMona Fiuzat, Justin Ezekowitz, Wendimagegn Alemayehu, et al.
Pageof 33